Results 81 to 90 of about 1,188 (177)

The link between smoking, emphysema, and fibrosis: A retrospective cohort study

Tobacco Induced Diseases
Introduction The presence of emphysema is common in patients with interstitial lung disease (ILD), which is designated as combined pulmonary fibrosis and emphysema (CPFE).
Liying Zhai, Haihong Gong, Wencheng Yu
doaj   +1 more source

Combined pulmonary fibrosis and emphysema with myeloperoxidase-antineutrophil cytoplasmic antibody positivity that resolved upon smoking cessation

Respiratory Medicine Case Reports, 2018
Myeloperoxidase antineutrophil cytoplasmic autoantibody (MPO-ANCA) is well-known as a serological marker for small-vessel vasculitis. However, when a smoker with interstitial lung disease (ILD) exhibits serum ANCA positivity without systemic vasculitis ...
Masahiro Nemoto, Satoshi Noma, Ayumu Otsuki, Kei Nakashima, Koichi Honma, Takeshi Johkoh, Junya Fukuoka, Masahiro Aoshima   +7 more
doaj   +1 more source

Combined pulmonary fibrosis and emphysema and lung transplantation: current evidence and future directions [PDF]

Background: Combined pulmonary fibrosis and emphysema (CPFE) patients generally have a poorer prognosis compared to those with either pulmonary fibrosis or chronic obstructive pulmonary disease (COPD)/emphysema alone, as demonstrated by several studies ...
Hage, René; https://orcid.org/, Clarenbach, Christian F; https://orcid.org/, Schuurmans, Macé M; https://orcid.org/, Frauenfelder, Thomas; https://orcid.org/   +3 more
core   +1 more source

Combined pulmonary fibrosis and emphysema: 3D time-resolved MR angiographic evaluation of pulmonary arterial mean transit time and time to peak enhancement [PDF]

, 2010
To correlate conventional invasive pressure indexes of pulmonary circulation with pulmonary first-order arterial mean transit time (MTT) and time to peak enhancement (TTP) measured by means of three-dimensional time-resolved magnetic resonance (MR ...
SERGIACOMI, GIANLUIGI, ROGLIANI, PAOLA, Cadioli, M, Fucci, F, SIMONETTI, GIOVANNI MARIA EGISTO, Simonetti, G, ROMEO, FRANCESCO, Crusco, S, Bolacchi, F, Angeli, M, Romeo, F, Pezzuto, G, Sergiacomi, G, Rogliani, P, Angeli, ML, Mariano, E   +15 more
core   +1 more source

The impact of combined pulmonary fibrosis and emphysema on mortality

, 2011
SETTING: The impact on patient mortality of combined pulmonary fibrosis and emphysema (CPFE) compared with emphysema alone has never been investigated. OBJECTIVE: To elucidate whether CPFE has an impact on overall mortality over that of emphysema alone ...
J. Y. Lee, Yang, S-C., K. Y. Lim, Y. W. Kim, Yoo, C-G., Y-S. Shim, J-J. Yim, C-G. Yoo, J. H. Yeon, Han, S. K., S. K. Han, Yim, J-J., C-H. Lee, D. J. Kim, S-S. Hwang, D-K. Kim, Lee, S-M., Kim, D. J., Kim, Y. W., Lee, C-H., C. M. Park, Lee, J. Y., Kim, D-K., Chung, H. S., Lim, K. Y., Park, C. M., S-C. Yang, S-M. Lee, H. S. Chung, Hwang, S-S., Kim, H. J., H. J. Kim, Shim, Y-S., Yeon, J. H.   +33 more
core   +1 more source

Mortality surrogates in combined pulmonary fibrosis and emphysema

Background Idiopathic pulmonary fibrosis (IPF) with coexistent emphysema, termed combined pulmonary fibrosis and emphysema (CPFE) may associate with reduced forced vital capacity (FVC) declines compared to non-CPFE IPF patients.
Mogulkoc, Nesrin, Young, Alexandra L, Porter, Joanna C, Duncan, Mark, Wuyts, Wim A, Ahmed, Asia, Vasudev, Pardeep, Verleden, Stijn, Goos, Tinne, Moodley, Yuben, Taliani, Alessandro, Wallis, Tim J M, Chapman, Robert, Barber, David, Janes, Sam M, Jones, Mark G, Zhao, An, van Es, Hendrik W, Taylor, Magali, van Beek, Frouke, Wells, Athol U, Veltkamp, Marcel, Tavanti, Laura, Jacob, Joseph, van Moorsel, Coline, Cross, Gary, Hopkins, Peter, Savas, Recep, Jo, Helen, Vermant, Marie, Brereton, Christopher J, De Liperi, Annalisa, Pontoppidan, Katarina, Procter, Alex, Gudmundsson, Eyjolfur, Barnett, Joseph, Romei, Chiara, Nair, Arjun, Corte, Tamera J, Stewart, Iain, Alexander, Daniel C, Denneny, Emma, De Sadeleer, Laurens J, Longziekten   +43 more
core   +3 more sources

Abstracts From PVRI 2026 Dublin

Pulmonary Circulation, Volume 16, Issue 2, April 2026.
wiley   +1 more source

Serum Krebs von den Lungen-6 as a potential biomarker for distinguishing combined pulmonary fibrosis and emphysema from chronic obstructive pulmonary disease: A retrospective study

Heliyon
Background: The presence of fibrotic interstitial lung disease (ILD) is relatively common in patients with emphysema. This has been designated combined pulmonary fibrosis and emphysema (CPFE). CPFE had worse prognosis than emphysema alone.
Aiyuan Zhou, Xiyan Zhang, Rongli Lu, Wenzhong Peng, Yanan Wang, Haiyun Tang, Pinhua Pan   +6 more
doaj   +1 more source

Clinical characteristics of combined pulmonary fibrosis and emphysema

, 2015
The definitive version is available at www.blackwell-synergy.comBackground and objective: Patients with combined pulmonary fibrosis and emphysema (CPFE) are sometimes seen, and we speculate that these patients have some different clinical characteristics
Kubo, Keishi, Fujimoto, Keisaku, Kitaguchi, Yoshiaki, Honda, Takayuki, Kawakami, Satoshi, Hanaoka, Masayuki   +5 more
core  

Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema

, 2019
Background: The aetiology and inflammatory profile of combined pulmonary fibrosis and emphysema (CPFE) remain uncertain currently. Objective: We aimed to examine the levels of inflammatory proteins in lung tissue in a cohort of patients with emphysema ...
He Wang (250350), Cynthia Kim (8041829), Huaqing Zhao (52078), Chandra Dass (8041835), Alejandra C. Lastra (8041832), Sudhir Bolla (8041838), Frederick V. Ramsey (6821327), William D. Cornwell (8041826), Thomas J. Rogers (8041841), Nathaniel Marchetti (3082398), Gerard J. Criner (8041844)   +10 more
core   +1 more source